Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years

Published:2022-03-24 Issue:5 Volume:37 Page:856-864
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Farlay Delphine¹^ORCID,Rizzo Sébastien¹,Dempster David W²³^ORCID,Huang Shuang⁴,Chines Arkadi⁴,Brown Jacques P⁵^ORCID,Boivin Georges¹^ORCID

Affiliation:

1. INSERM, UMR 1033 University of Lyon, Université Claude Bernard Lyon 1 Lyon France

2. Department of Pathology and Cell Biology Columbia University New York NY USA

3. Regional Bone Center Helen Hayes Hospital West Haverstraw NY USA

4. Clinical Development Amgen Inc. Thousand Oaks CA USA

5. CHU de Quebec Research Centre Laval University Quebec City Canada

Funder

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4538

Reference24 articles.

1. Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

2. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

3. Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

4. Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

5. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of anti-fracture medications on bone material and strength properties: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-08-27

2. Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling;Phytomedicine;2024-06

3. Aktuelle und zukünftige pharmakologische Therapieoptionen zur Behandlung der Osteoporose und deren Wirkmechanismen – ein Überblick;Osteologie;2024-05

4. Bone Mineral Density is Related to CD4+ T Cell Counts and Muscle Mass is Associated with B Cells in Common Variable Immunodeficiency Patients;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-02

5. Long-term and sequential treatment for osteoporosis;Nature Reviews Endocrinology;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3